The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis

Experimental Cell Research

Volumn 315, Issue 5, 2009, Pages 760-768

  Reich III, Charles F ^a,b   Pisetsky, David S ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; DNA; Microparticles; Necrosis; RNA

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP)(PHOSPHORYLATING); MESSENGER RNA; MONOCLONAL ANTIBODY; NUCLEIC ACID; RNA 18S; RNA 28S;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CENTRIFUGATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA CONTENT; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA DEGRADATION;

EID: 59849112828     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.12.014     Document Type: Article

References (44)

1. VanWijk M.J., VanBavel E., Sturk A., and Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc. Res. 59 (2003) 277-287
2. Horstman L.L., Jy W., Jimenez J.J., Bidot C., and Ahn Y.S. New horizons in the analysis of circulating cell-derived microparticles. Keio J. Med. 53 (2004) 210-230
3. Distler J.H., Pisetsky D.S., Huber L.C., Kalden J.R., Gay S., and Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 52 (2005) 3337-3348
4. Lane J.D., Allan V.J., and Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell. Sci. 118 (2005) 4059-4071
5. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., and Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 15 (2008) 183-191
6. Hasselmann D.O., Rappl G., Tilgen W., and Reinhold U. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin. Chem. 47 (2001) 1488-1489
7. Ng E.K., Tsui N.B., Lam N.Y., Chiu R.W., Yu S.C., Wong S.C., Lo E.S., Rainer T.H., Johnson P.J., and Lo Y.M. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin. Chem. 48 (2002) 1212-1217
8. El-Hefnawy T., Raja S., Kelly L., Bigbee W.L., Kirkwood J.M., Luketich J.D., and Godfrey T.E. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50 (2004) 564-573
9. Kopreski M.S., Benko F.A., Kwak L.W., and Gocke C.D. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin. Cancer Res. 5 (1999) 1961-1965
10. Lo K.W., Lo Y.M., Leung S.F., Tsang Y.S., Chan L.Y., Johnson P.J., Hjelm N.M., Lee J.C., and Huang D.P. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 45 (1999) 1292-1294
11. Rappl G., Hasselmann D.O., Rossler M., Ugurel S., Tilgen W., and Reinhold U. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma. Ann. N.Y. Acad. Sci. 945 (2001) 189-191
12. Dasi F., Lledo S., Garcia-Granero E., Ripoll R., Marugan M., Tormo M., Garcia-Conde J., and Alino S.F. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest. 81 (2001) 767-769
13. Wong S.C., Lo S.F., Cheung M.T., Ng K.O., Tse C.W., Lai B.S., Lee K.C., and Lo Y.M. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10 (2004) 1613-1617
14. Sueoka E., Sueoka N., Iwanaga K., Sato A., Suga K., Hayashi S., Nagasawa K., and Nakachi K. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer 48 (2005) 77-83
15. Halicka H.D., Bedner E., and Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp. Cell Res. 260 (2000) 248-256
16. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol. 25 (2004) 381-386
17. Schroder M., and Bowie A.G. TLR3 in antiviral immunity: key player or bystander?. Trends Immunol. 26 (2005) 462-468
18. Meylan E., and Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22 (2006) 561-569
19. Meylan E., Tschopp J., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
20. Trinchieri G., and Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7 (2007) 179-190
21. Lovgren T., Eloranta M.L., Bave U., Alm G.V., and Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 50 (2004) 1861-1872
22. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115 (2005) 407-417
23. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., and Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8 (2007) 487-496
24. Graves L.E., Ariztia E.V., Navari J.R., Matzel H.J., Stack M.S., and Fishman D.A. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 64 (2004) 7045-7049
25. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., and Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20 (2006) 1487-1495
26. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., Urbanowicz B., Branski P., Ratajczak M.Z., and Zembala M. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55 (2006) 808-818
27. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., Baran J., and Zembala M. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol. Lett. 113 (2007) 76-82
28. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., and Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007) 654-659
29. Houge G., Doskeland S.O., Boe R., and Lanotte M. Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis. FEBS Lett. 315 (1993) 16-20
30. Houge G., Robaye B., Eikhom T.S., Golstein J., Mellgren G., Gjertsen B.T., Lanotte M., and Doskeland S.O. Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol. Cell. Biol. 15 (1995) 2051-2062
31. Samali A., Gilje B., Doskeland S.O., Cotter T.G., and Houge G. The ability to cleave 28S ribosomal RNA during apoptosis is a cell-type dependent trait unrelated to DNA fragmentation. Cell Death Differ. 4 (1997) 289-293
32. King K.L., Jewell C.M., Bortner C.D., and Cidlowski J.A. 28S ribosome degradation in lymphoid cell apoptosis: evidence for caspase and Bcl-2-dependent and -independent pathways. Cell Death Differ. 7 (2000) 994-1001
33. Degen W.G., Pruijn G.J., Raats J.M., and van Venrooij W.J. Caspase-dependent cleavage of nucleic acids. Cell Death Differ. 7 (2000) 616-627
34. Hoat T.X., Nakayashiki H., Tosa Y., and Mayama S. Specific cleavage of ribosomal RNA and mRNA during victorin-induced apoptotic cell death in oat. Plant J. 46 (2006) 922-933
35. Crawford D.R., Lauzon R.J., Wang Y., Mazurkiewicz J.E., Schools G.P., and Davies K.J. 16S mitochondrial ribosomal RNA degradation is associated with apoptosis. Free Radic. Biol. Med. 22 (1997) 1295-1300
36. Samejima K., and Earnshaw W.C. Trashing the genome: the role of nucleases during apoptosis. Nat. Rev. Mol. Cell Biol. 6 (2005) 677-688
37. Sobol P.T., and Mossman K.L. ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells. J. Virol. 80 (2006) 218-225
38. Ng E.K., Tsui N.B., Lau T.K., Leung T.N., Chiu R.W., Panesar N.S., Lit L.C., Chan K.W., and Lo Y.M. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4748-4753
39. Larrabee P.B., Johnson K.L., Lai C., Ordovas J., Cowan J.M., Tantravahi U., and Bianchi D.W. Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA 293 (2005) 836-842
40. Fan J., Yang X., Wang W., Wood III W.H., Becker K.G., and Gorospe M. Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10611-10616
41. Taxman D.J., MacKeigan J.P., Clements C., Bergstralh D.T., and Ting J.P. Transcriptional profiling of targets for combination therapy of lung carcinoma with paclitaxel and mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor. Cancer Res. 63 (2003) 5095-5104
42. Lu X., Burgan W.E., Cerra M.A., Chuang E.Y., Tsai M.H., Tofilon P.J., and Camphausen K. Transcriptional signature of flavopiridol-induced tumor cell death. Mol. Cancer Ther. 3 (2004) 861-872
43. Lu X., de la Pena L., Barker C., Camphausen K., and Tofilon P.J. Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res. 66 (2006) 1052-1061
44. Radic M., Marion T., and Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 172 (2004) 6692-6700